Menu
Recruiting NCT07427199

Effect of Digitally Supported Medical Nutrition Therapy on Left Ventricular Ejection Fraction in Patients With ST-Elevation Myocardial Infarction

No phase Interventional ST-elevation Myocardial Infarction (STEMI)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Digital Content-Supported Medical Nutrition Therapy.
Who it may be relevant to
Registry conditions: ST-elevation Myocardial Infarction (STEMI). Basic parameters: 19 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of Digitally Supported Medical Nutrition Therapy on Left Ventricular Ejection Fraction in Patients With ST-Elevation Myocardial Infarction: A Randomized Controlled Trial

Overview

This study is designed to investigate the effect of a nutrition program supported by digital content on heart function in patients who have experienced a heart attack with ST-elevation. Participants will receive personalized dietary guidance and digital support materials for three months. The main goal is to determine whether this digital support materials can improve heart pumping function (measured by left ventricular ejection fraction). Participation involves following the dietary program and undergoing heart function measurements at the beginning, after one months and after three months.

Interventions

  • Behavioral Digital Content-Supported Medical Nutrition Therapy
    Participants receive a personalized medical nutrition therapy program supported by digital content. The program includes educational materials, meal planning guides, and remote support. The intervention lasts 3 months, with follow-up visits at baseline, 1 month, and 3 months. Heart function (LVEF) will be measured at each time point.

Primary outcome measures

  • Left Ventricular Ejection Fraction (LVEF) [Time frame: Baseline, 1 month, 3 months]

Eligibility criteria

Inclusion criteria

  • Individuals aged 19-65 who have fully completed the voluntary consent form
  • Being of normal weight (BMI 18.5-24.9 kg/m²) or obese (30-34.99 kg/m²)
  • Having suffered a heart attack with ST elevation (STEMI)
  • To be enrolled in the study within the first 72 hours after hospital admission
  • To be willing to participate in a follow-up period of at least 3 months

Exclusion criteria

  • Those who did not sign the voluntary consent form
  • Individuals aged over 65
  • Weight loss exceeding 5% in the last 3 months
  • Those with malignancy, chronic renal failure or severe systemic disease
  • Patients unable to complete the questionnaires due to severe cognitive impairment
  • Those who have previously received nutrition education or eating awareness training

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Ondokuz Mayıs Üniversitesi Tıp Fakültesi Hastanesi — Samsun

Identifiers

NCT: NCT07427199 · 2025/012

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗